Abstract
Aim
To highlight the use of automatic quantification of immunochemical staining on digitized images of whole tumor sections in preclinical positron emission tomography (PET) studies.
Materials and methods
Xenografted human testicular tumors (36) were imaged with 2-deoxy-2[F-18]fluoro-d-glucose (FDG) small animal PET (SA-PET). Tumor cell proliferation and glucose transportation were assessed with cyclin A and Glut-1 immunostaining. Tumor slides were digitized and processed with PixCyt® software enabling whole slide quantification, then compared with junior and senior pathologist manual scoring. Manual and automatic quantification results were correlated to FDG uptake.
Results
For cyclin A, inter- and intra-observer agreement for manual scoring was 0.52 and 0.72 and concordance between senior pathologist and automatic quantification was 0.84. Correlations between Tumor/Background ratio and tumor cell proliferation assessed by automatic quantification, junior and senior pathologists were 0.75, 0.55, and 0.61, respectively. Correlation between Tumor/Background ratio and Glut-1 assessed by automatic quantification was 0.74.
Conclusion
Automatic quantification of immunostaining is a valuable tool to overcome inter- and intra-observer variability for correlation of cell proliferation or other markers with tumor tracer uptake.
Similar content being viewed by others
References
Nanni C, Di Leo K, Tonelli R et al (2007) FDG small animal PET permits early detection of malignant cells in a xenograft murine model. Eur J Nucl Med Mol Imaging 34:755–762
Aliaga A, Rousseau JA, Cadorette J et al (2007) A small animal positron emission tomography study of the effect of chemotherapy and hormonal therapy on the uptake of 2-deoxy-2-[F-18]fluoro-d-glucose in murine models of breast cancer. Mol Imaging Biol 9:144–150
Cullinane C, Dorow DS, Kansara M et al (2005) An in vivo tumor model exploiting metabolic response as a biomarker for targeted drug development. Cancer Res 65:9633–9636
Dorow DS, Cullinane C, Conus N et al (2006) Multi-tracer small animal PET imaging of the tumour response to the novel pan-Erb-B inhibitor CI-1033. Eur J Nucl Med Mol Imaging 33:441–452
Nanni C, Rubello D, Khan S, Al Nahhas A, Fanti S (2007) Role of small animal PET in stimulating the development of new radiopharmaceuticals in oncology. Nucl Med Commun 28:427–429
Nanni C, Rubello D, Fanti S (2007) Role of small animal PET for molecular imaging in pre-clinical studies. Eur J Nucl Med Mol Imaging 34:1819–1822
Molthoff CF, Klabbers BM, Berkhof J et al (2007) Monitoring response to radiotherapy in human squamous cell cancer bearing nude mice: comparison of 2¢-deoxy-2¢-[(18)F]fluoro-d:-glucose (FDG) and 3¢-[(18)F]fluoro-3¢-deoxythymidine (FLT). Mol Imaging Biol 9:340–347
Brepoels L, Stroobants S, Vandenberghe P et al (2007) Effect of corticosteroids on 18F-FDG uptake in tumor lesions after chemotherapy. J Nucl Med 48:390–397
Leyton J, Latigo JR, Perumal M, Dhaliwal H, He Q, Aboagye EO (2005) Early detection of tumor response to chemotherapy by 3¢-deoxy-3¢-[18F]fluorothymidine positron emission tomography: the effect of cisplatin on a fibrosarcoma tumor model in vivo. Cancer Res 65:4202–4210
Huisman MC, Reder S, Weber AW, Ziegler SI, Schwaiger M (2006) Performance evaluation of the Philips MOSAIC small animal PET scanner. Eur J Nucl Med Mol Imaging 34:532–540
Chiang S, Cardi C, Matej S et al (2004) Clinical validation of fully 3-D versus 2.5-D RAMLA reconstruction on the Philips-ADAC CPET PET scanner. Nucl Med Commun 25:1103–1107
Aide N, Louis MH, Dutoit S et al (2007) Improvement of semi-quantitative small-animal PET data with recovery coefficients: a phantom and rat study. Nucl Med Commun 28:813–822
Calvet L, Geoerger B, Regairaz M et al (2006) Pleiotrophin, a candidate gene for poor tumor vasculature and in vivo neuroblastoma sensitivity to irinotecan. Oncogene 25:3150–3159
Elie N, Plancoulaine B, Signolle JP, Herlin P (2003) A simple way of quantifying immunostained cell nuclei on the whole histologic section. Cytometry A 56:37–45
Elie N, Kaliski A, Peronneau P, Opolon P, Roche A, Lassau N (2007) Methodology for quantifying interactions between perfusion evaluated by DCE-US and hypoxia throughout tumor growth. Ultrasound Med Biol 33:549–560
Galaup A, Cazes A, Le Jan S et al (2006) Angiopoietin-like 4 prevents metastasis through inhibition of vascular permeability and tumor cell motility and invasiveness. Proc Natl Acad Sci U S A 103:18721–18726
Vesselle H, Schmidt RA, Pugsley JM et al (2000) Lung cancer proliferation correlates with [F-18]fluorodeoxyglucose uptake by positron emission tomography. Clin Cancer Res 6:3837–3844
Howard CV, Reed MG (1998) Unbiased stereology: three-dimensional measurement in microscopy. BIOS Scientific, London
Riedl CC, Akhurst T, Larson S et al (2007) 18F-FDG PET scanning correlates with tissue markers of poor prognosis and predicts mortality for patients after liver resection for colorectal metastases. J Nucl Med 48:771–775
Yamamoto Y, Nishiyama Y, Ishikawa S et al (2007) Correlation of (18)F-FLT and (18)F-FDG uptake on PET with Ki-67 immunohistochemistry in non-small cell lung cancer. Eur J Nucl Med Mol Imaging 34:1610–1616
Aide N, Briand M, Dutoit S et al (2007) Early evaluation of chemotherapy effect with longitudinal fluorodeoxyglucose (FDG) small animal PET (SA-PET) in human testicular cancer xenografts. Eur J Nucl Med Mol Imaging 34:S298
Desdouets C, Sobczak-Thepot J, Murphy M, Brechot C (1995) Cyclin A: function and expression during cell proliferation. Prog Cell Cycle Res 1:115–123
Yam CH, Fung TK, Poon RY (2002) Cyclin A in cell cycle control and cancer. Cell Mol Life Sci 59:1317–1326
Ishibashi H, Suzuki T, Suzuki S et al (2005) Progesterone receptor in non-small cell lung cancer—a potent prognostic factor and possible target for endocrine therapy. Cancer Res 65:6450–6458
Kubota R, Yamada S, Kubota K, Ishiwata K, Tamahashi N, Ido T (1992) Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med 33:1972–1980
Acknowledgments
The authors wish to thank Edwige Deslandes for cell line management, Mélanie Briand for her help during small animal PET acquisitions, Natacha Heutte for the statistical studies and Mylene Brécin for her help during whole slide scanning. Heather Costil is thanked for manuscript editing.
Author information
Authors and Affiliations
Corresponding author
Additional information
This work was supported by a grant from the French Ligue Contre le Cancer, Comité du Calvados. Alexandre Labiche received a fellowship from the Ligue Contre le Cancer, Comité de la Manche.
Rights and permissions
About this article
Cite this article
Aide, N., Labiche, A., Herlin, P. et al. Usefulness of Automatic Quantification of Immunochemical Staining on Whole Tumor Sections for Correlation with Oncological Small Animal PET Studies: An Example with Cell Proliferation, Glucose Transporter 1 and FDG. Mol Imaging Biol 10, 237–244 (2008). https://doi.org/10.1007/s11307-008-0144-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11307-008-0144-5